Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2010 1
2011 1
2013 1
2014 4
2015 3
2016 5
2018 2
2019 10
2020 1
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.
Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, Vogl DT, Weiss BM, Dengel K, Nelson A, Plesa G, Chen F, Davis MM, Hwang WT, Young RM, Brogdon JL, Isaacs R, Pruteanu-Malinici I, Siegel DL, Levine BL, June CH, Milone MC. Cohen AD, et al. Among authors: garfall al. J Clin Invest. 2019 Mar 21;129(6):2210-2221. doi: 10.1172/JCI126397. J Clin Invest. 2019. PMID: 30896447 Free PMC article. Clinical Trial.
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, Greenplate AR, Hwee MA, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman AR, Ittner CAG, Kugler EM, Baxter AE, Oniyide O, Agyekum RS, Dunn TG, Jones TK, Giannini HM, Weirick ME, McAllister CM, Babady NE, Kumar A, Widman AJ, DeWolf S, Boutemine SR, Roberts C, Budzik KR, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles JR, Oldridge DA, Wu JE, Alanio C, Adamski S, Garfall AL, Vella LA, Kerr SJ, Cohen JV, Oyer RA, Massa R, Maillard IP, Maxwell KN, Reilly JP, Maslak PG, Vonderheide RH, Wolchok JD, Hensley SE, Wherry EJ, Meyer NJ, DeMichele AM, Vardhana SA, Mamtani R, Huang AC. Bange EM, et al. Among authors: garfall al. Nat Med. 2021 Jul;27(7):1280-1289. doi: 10.1038/s41591-021-01386-7. Epub 2021 May 20. Nat Med. 2021. PMID: 34017137 Free PMC article.
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.
Usmani SZ, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Rosinol L, Chari A, Bhutani M, Karlin L, Benboubker L, Pei L, Verona R, Girgis S, Stephenson T, Elsayed Y, Infante J, Goldberg JD, Banerjee A, Mateos MV, Krishnan A. Usmani SZ, et al. Among authors: garfall al. Lancet. 2021 Aug 21;398(10301):665-674. doi: 10.1016/S0140-6736(21)01338-6. Epub 2021 Aug 10. Lancet. 2021. PMID: 34388396 Clinical Trial.
Trials and Tribulations with VH Replacement.
Meng W, Jayaraman S, Zhang B, Schwartz GW, Daber RD, Hershberg U, Garfall AL, Carlson CS, Luning Prak ET. Meng W, et al. Among authors: garfall al. Front Immunol. 2014 Jan 30;5:10. doi: 10.3389/fimmu.2014.00010. eCollection 2014. Front Immunol. 2014. PMID: 24523721 Free PMC article. Review.
Cellular and vaccine immunotherapy for multiple myeloma.
Garfall AL, Stadtmauer EA. Garfall AL, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):521-527. doi: 10.1182/asheducation-2016.1.521. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913524 Free PMC article. Review.
Cellular immunotherapy for plasma cell myeloma.
Garfall AL, Vogl DT, Weiss BM, Stadtmauer EA. Garfall AL, et al. Bone Marrow Transplant. 2013 Nov;48(11):1377-86. doi: 10.1038/bmt.2013.54. Epub 2013 May 6. Bone Marrow Transplant. 2013. PMID: 23645169 Review.
Axicabtagene ciloleucel for CD19+ plasmablastic lymphoma.
Raychaudhuri R, Qualtieri J, Garfall AL. Raychaudhuri R, et al. Among authors: garfall al. Am J Hematol. 2020 Jan;95(1):E28-E30. doi: 10.1002/ajh.25682. Epub 2019 Nov 25. Am J Hematol. 2020. PMID: 31725923 Free article. No abstract available.
Multitargeted CAR T-cell therapy in multiple myeloma.
Susanibar Adaniya S, Garfall AL. Susanibar Adaniya S, et al. Among authors: garfall al. Lancet Haematol. 2019 Oct;6(10):e494-e495. doi: 10.1016/S2352-3026(19)30165-6. Epub 2019 Aug 1. Lancet Haematol. 2019. PMID: 31378663 No abstract available.
34 results